Notice Number: NOT-AA-09-001

Key Dates
Release Date:  March 12, 2009

Issued by
National Institute on Alcohol Abuse and Alcoholism (NIAAA), (http://www.niaaa.nih.gov/)

Purpose

This Notice announces the participation of the NATIONAL INSTITUTE OF ALCOHOL ABUSE AND ALCOHOLISM (NIAAA) in PA-09-106 (R01) and PA-09-107(R21) entitled “Medications Development for the Treatment of Pregnant/Postpartum Women with Substance Related Disorders and/or In Utero Substance Exposed Neonates.” .

The following Institute continues to participate in PA-09-106 and PA-09-107:
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov/)

All other aspects of these Program Announcements remain unchanged.

Inquiries

Inquiries and discussion of plans for responding to this Notice are strongly encouraged.

Program Contact:

Dale Hereld, M.D., Ph.D.
Division of Metabolism and Health Effects
National Institute on Alcohol Abuse and Alcoholism
5635 Fishers Lane, Room 2027, MSC 9304
Bethesda, MD 20892-9304
Telephone: (301) 443-0912
FAX:  (301) 594-0673
Email: hereldd@mail.nih.gov

Grants Management Contact:

Judy Fox
Grants Management Branch
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health, DHHS
5635 Fishers Lane MSC 9304 Room 3023
Bethesda, MD 20892-9304
[For express mail use: Rockville, MD 20852-1705]
Telephone: 301-443-4704
FAX:  301-443-3891
Email:  jfox@mail.nih.gov

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files.